For example, recent reports demonstrated that high expression of GATA2 and AIB1/SRC3 is predictive of poor outcome in prostate cancer and modulates the expression of key androgen-regulated genes that have potential roles in the transition of prostate cancer cells to aggressive phenotype (18,29). This evidence concerns the gene GATA2 and prostate carcinoma.